每年專案
機構檔案
機構簡介
臺北醫學大學投入癌症治療研究多年，在中草藥、新藥合成、新藥開發和機轉研究上展現全方位的基礎研究能量，三家附屬醫院也都設置癌症研究中心，分別致力於各項癌症的轉譯研究。醫學科技學院(College of Medical Science and Technology, TMU)成立於2010年，依校方的長遠發展政策，將本校以醫學院為主體的學院結構予以重整，以醫療應用領域之系所為主體，於99學年度創立「醫學科技學院」，本院以轉譯醫學之教學與研究為主軸，發展國際跨領域研究，建立學院特色領域。
指紋
查看啟用 醫學科技學院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
網路
國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。
概要
專案
研究成果
-
Aged skeletal muscle retains the ability to remodel extracellular matrix for degradation of collagen deposition after muscle injury
Chen, W. J., Lin, I. H., Lee, C. W. & Chen, Y. F., 二月 2 2021, 於: International journal of molecular sciences. 22, 4, p. 1-14 14 p., 2123.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
An integrated bioinformatics study of a novel niclosamide derivative, nsc765689, a potential gsk3β/β-catenin /stat3/ cd44 suppressor with anti-glioblastoma properties
Mokgautsi, N., Wen, Y. T., Lawal, B., Khedkar, H., Sumitra, M. R., Wu, A. T. H. & Huang, H. S., 三月 1 2021, 於: International journal of molecular sciences. 22, 5, p. 1-23 23 p., 2464.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling
Chang, T. Y., Nepali, K., Chen, Y. Y., Yang, Y. C. S. H., Hsu, K. C., Yen, Y., Pan, S. L., Liou, J. P. & Lee, S. B., 六月 2021, 於: Biomedicine and Pharmacotherapy. 138, 111485.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Lin, C. (Contributor), Hsu, K. (Contributor), HuangFu, W. (Contributor), Lin, T. E. (Contributor), Huang, H. (Contributor) & Pan, S. (Contributor), Unknown Publisher, 三月 12 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Investigating_the_potential_effects_of_selective_histone_deacetylase_6_inhibitor_ACY1215_on_infarct_size_in_rats_with_cardiac_ischemia-reperfusion_injury/11992497/1
資料集: Dataset
-
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H. (Contributor), Lin, Y. (Contributor), Chao, M. (Contributor), Sung, T. (Contributor), Wu, Y. (Contributor), Chen, Y. (Contributor), Lin, M. (Contributor), Liou, J. (Contributor), Pan, S. (Contributor) & Yang, C. (Contributor), Unknown Publisher, 十二月 29 2018
DOI: 10.6084/m9.figshare.c.4350887.v1, https://springernature.figshare.com/collections/The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/4350887/1
資料集: Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T. (Contributor), Hsieh, Y. (Contributor), Chou, C. (Contributor) & Yang, P. (Contributor), Unknown Publisher, 一月 1 2018
DOI: 10.6084/m9.figshare.7375601.v1, https://rs.figshare.com/articles/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7375601/1
資料集: Dataset